We are excited to launch our new orthotopic model of human glioblastoma. We use cutting-edge technology such as patient-derived xenografts (PDX) and in vivo bioluminescence imaging. Join us today on our quest for accelerating preclinical drug discovery and combating brain cancer. Explore this and other segment models here: https://ivrs.se/segment-models/
If you have any questions or would like to explore how our expertise can support the next steps in your preclinical pipeline, don’t hesitate to contact us at info@ivrs.se. We look forward to assisting you in advancing breast cancer research and drug development.
